North Dakota State Investment Board Acquires New Position in GE HealthCare Technologies Inc. $GEHC

North Dakota State Investment Board acquired a new stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 15,698 shares of the company’s stock, valued at approximately $1,288,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of GEHC. Empowered Funds LLC increased its holdings in GE HealthCare Technologies by 6.1% in the first quarter. Empowered Funds LLC now owns 28,848 shares of the company’s stock valued at $2,328,000 after buying an additional 1,665 shares during the last quarter. Acadian Asset Management LLC bought a new stake in GE HealthCare Technologies in the first quarter valued at about $259,000. Cresset Asset Management LLC increased its holdings in GE HealthCare Technologies by 12.5% in the second quarter. Cresset Asset Management LLC now owns 7,802 shares of the company’s stock valued at $578,000 after buying an additional 865 shares during the last quarter. Jump Financial LLC increased its holdings in GE HealthCare Technologies by 317.6% in the second quarter. Jump Financial LLC now owns 28,132 shares of the company’s stock valued at $2,084,000 after buying an additional 21,396 shares during the last quarter. Finally, Gamco Investors INC. ET AL increased its holdings in GE HealthCare Technologies by 8.6% in the second quarter. Gamco Investors INC. ET AL now owns 4,041 shares of the company’s stock valued at $299,000 after buying an additional 320 shares during the last quarter. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Stock Performance

Shares of GEHC stock opened at $61.56 on Wednesday. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. The business has a 50 day moving average of $69.02 and a two-hundred day moving average of $76.48. GE HealthCare Technologies Inc. has a 52 week low of $58.75 and a 52 week high of $89.77. The company has a market cap of $28.00 billion, a P/E ratio of 14.73, a PEG ratio of 1.38 and a beta of 0.74.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.08). The business had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.04 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The business’s quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.01 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, analysts anticipate that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

More GE HealthCare Technologies News

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: Argus kept a Buy rating on GE HealthCare while lowering its price target to $80 from $95, suggesting analysts still see upside from current levels despite trimming expectations. Article Link
• Neutral Sentiment: Another report said GE HealthCare is receiving an average analyst rating of Hold, which points to cautious sentiment but does not by itself change the investment case. Article Link
• Negative Sentiment: Kirby McInerney LLP said it is investigating potential claims involving GE HealthCare and possible violations of federal securities laws, adding to legal uncertainty for shareholders. Article Link
• Negative Sentiment: Bragar Eagel & Squire also said it continues investigating GEHC on behalf of stockholders, reinforcing the litigation overhang. Article Link
• Negative Sentiment: Glancy Prongay Wolke & Rotter announced a securities-fraud investigation into GE HealthCare, and Law Offices of Howard G. Smith separately launched a similar probe, increasing concerns about potential legal costs and reputational damage. Article Link Article Link

Analyst Ratings Changes

Several analysts recently weighed in on the company. Barclays lowered their price objective on GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating for the company in a report on Thursday, April 30th. Citigroup decreased their target price on GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating for the company in a research note on Thursday, April 30th. Jefferies Financial Group decreased their target price on GE HealthCare Technologies from $105.00 to $90.00 in a research note on Thursday, April 30th. Evercore set a $80.00 target price on GE HealthCare Technologies in a research note on Thursday, April 30th. Finally, JPMorgan Chase & Co. decreased their target price on GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating for the company in a research note on Thursday, April 30th. Nine investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $80.63.

Insider Buying and Selling at GE HealthCare Technologies

In other GE HealthCare Technologies news, insider Frank R. Jimenez acquired 1,750 shares of GE HealthCare Technologies stock in a transaction dated Thursday, April 30th. The stock was acquired at an average cost of $60.45 per share, for a total transaction of $105,787.50. Following the completion of the transaction, the insider owned 93,932 shares in the company, valued at approximately $5,678,189.40. This represents a 1.90% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CFO James Saccaro acquired 3,310 shares of GE HealthCare Technologies stock in a transaction dated Friday, May 1st. The shares were acquired at an average price of $60.60 per share, with a total value of $200,586.00. Following the completion of the transaction, the chief financial officer owned 87,471 shares of the company’s stock, valued at approximately $5,300,742.60. This trade represents a 3.93% increase in their position. The SEC filing for this purchase provides additional information. In the last 90 days, insiders acquired 11,847 shares of company stock valued at $719,555. 0.36% of the stock is currently owned by insiders.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.